LUCENTIS Side Effects

6884081-1 | Arteriosclerosis, Fall, Haemorrhage Intracranial, Head Injury, Skull Fracture, Subarachnoid Haemorrhage
on Jul 13, 2010 Female patient from SWITZERLAND , 84 years of age, was diagnosed with cardiac failure and was treated with Lucentis (View Usage). Patient experienced the following unwanted or unexpected effects: arteriosclerosis, fall (What is fall?), haemorrhage intracranial, head injury, skull fracture, subarachnoid haemorrhage. Lucentis dosage: Unk. During the same period patient was treated with BENDROFLUAZIDE (View Bendrofluazide Review and Bendrofluazide Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6881337-3 | Conjunctival Filtering Bleb Leak, Corneal Oedema, Eye Operation, Hypotony Of Eye, Lacrimation Increased, Ocular Discomfort, Vision Blurred, Visual Acuity Reduced
Patient was taking Lucentis (View Usage). Patient had the following side effects: conjunctival filtering bleb leak, corneal oedema, eye operation, hypotony of eye, lacrimation increased, ocular discomfort, vision blurred, visual acuity reduced on Jul 15, 2010 from SWITZERLAND Additional patient health information: Male patient , 71 years of age, . Lucentis dosage: . During the same period patient was treated with TOBRAMYCIN (View Tobramycin Review and Tobramycin Label ).

6870144-3 | Cerebellar Infarction, Incontinence, Lacunar Infarction
Adverse event was reported on Jul 08, 2010 by a Male patient taking Lucentis (View Usage) (Dosage: 0.05 Ml Daily Ey) . Location: JAPAN , 81 years of age, After Lucentis was administered, patient had the following side effects: cerebellar infarction, incontinence, lacunar infarction. During the same period patient was treated with VISUDYNE (View Visudyne Review and Visudyne Label ), MOXIFLOXACIN HYDROCHLORIDE (View Moxifloxacin Hydrochloride Review and Moxifloxacin Hydrochloride Label ), RINDERON (View Rinderon Review and Rinderon Label ), SOLANTAL (View Solantal Review and Solantal Label ). Patient was hospitalized.

6867354-8 | Eye Haemorrhage, Injection Site Pain
on Jul 07, 2010 Female patient from SWITZERLAND , 85 years of age, was treated with Lucentis (View Usage). Patient experienced the following unwanted or unexpected effects: eye haemorrhage, injection site pain. Lucentis dosage: Unk.


6860979-5 | Bradycardia
on Jul 07, 2010 Male patient from SWITZERLAND , 69 years of age, was treated with Lucentis (View Usage). Patient had the following side effects: bradycardia. Lucentis dosage: 1 Mg, 1/month. During the same period patient was treated with LISINOPRIL AND HYDROCHLOROTHIAZIDE (View Lisinopril And Hydrochlorothiazide Review and Lisinopril And Hydrochlorothiazide Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6860965-5 | Femur Fracture
Patient was taking Lucentis (View Usage). After Lucentis was administered, patient had the following side effects: femur fracture on Jul 06, 2010 from SWITZERLAND Additional patient health information: Female patient , 91 years of age, . Lucentis dosage: 1 Amp, 1/month.

6860961-8 | Cerebrovascular Accident
Adverse event was reported on Jul 05, 2010 by a Female patient taking Lucentis (View Usage) (Dosage: 5 Mg, Unk) . Location: SWITZERLAND , 83 years of age, Patient experienced the following unwanted or unexpected effects: cerebrovascular accident.

6858031-8 | Myocardial Ischaemia
on Jul 02, 2010 Male patient from SWITZERLAND , 92 years of age, was treated with Lucentis (View Usage). Patient had the following side effects: myocardial ischaemia. Lucentis dosage: 0.5 Mg, Unk. During the same period patient was treated with FRUMIL (Unk) (View Frumil Review and Frumil Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized.

6857228-0 | Acute Myocardial Infarction
on Jul 05, 2010 Male patient from SWITZERLAND , 89 years of age, was treated with Lucentis (View Usage). After Lucentis was administered, patient had the following side effects: acute myocardial infarction. Lucentis dosage: 0.5 Mg, Unk. Patient was hospitalized.

6849691-6 | Cerebrovascular Accident
Patient was taking Lucentis (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident on Jul 02, 2010 from SWITZERLAND Additional patient health information: Female patient , 74 years of age, was diagnosed with hypertension and. Lucentis dosage: Unk. During the same period patient was treated with ANTIHYPERTENSIVES (View Antihypertensives Review and Antihypertensives Label ).

6842232-9 | Transient Ischaemic Attack
Adverse event was reported on Apr 06, 2007 by a Male patient taking Lucentis (View Usage) (Dosage: 3 Mg, Unk) . Location: UNITED STATES , weighting 149.9 lb, Patient had the following side effects: transient ischaemic attack. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ACTOS (View Actos Review and Actos Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ).

6840909-2 | Choroidal Detachment, Retinal Pigmentation
on Jul 01, 2010 Female patient from SWITZERLAND , 88 years of age, was treated with Lucentis (View Usage). After Lucentis was administered, patient had the following side effects: choroidal detachment, retinal pigmentation. Lucentis dosage: .

6836226-7 | Agitation, Cerebrovascular Accident
on Jun 29, 2010 Female patient from BELGIUM , 79 years of age, was treated with Lucentis (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, cerebrovascular accident. Lucentis dosage: Unk. During the same period patient was treated with TENORMIN (View Tenormin Review and Tenormin Label ), MACUGEN (Unk) (View Macugen Review and Macugen Label ). Patient was hospitalized and became disabled.

6835909-2 | Myocardial Infarction
Patient was taking Lucentis (View Usage). Patient had the following side effects: myocardial infarction on Jun 28, 2010 from SWITZERLAND Additional patient health information: Female patient , 86 years of age, . Lucentis dosage: Unk. During the same period patient was treated with LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), SERETIDE (View Seretide Review and Seretide Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

6827243-1 | Corneal Erosion
Adverse event was reported on Jun 25, 2010 by a Male patient taking Lucentis (View Usage) (Dosage: ) . Location: SWITZERLAND , 70 years of age, After Lucentis was administered, patient had the following side effects: corneal erosion. During the same period patient was treated with POVIDONE IODINE (View Povidone Iodine Review and Povidone Iodine Label ).

6821364-5 | Abortion Spontaneous
on Jun 21, 2010 Female patient from SWITZERLAND , weighting 143.3 lb, was treated with Lucentis (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous. Lucentis dosage: Unk.

6818683-5 | Retinal Pigment Epithelial Tear, Scotoma, Visual Acuity Reduced
on Jun 23, 2010 Male patient from SWITZERLAND , weighting 158.7 lb, was treated with Lucentis (View Usage). Patient had the following side effects: retinal pigment epithelial tear, scotoma, visual acuity reduced. Lucentis dosage: 0.05 Ml, Unk. During the same period patient was treated with VISUDYNE (Unk) (View Visudyne Review and Visudyne Label ), PANALDINE (Unk) (View Panaldine Review and Panaldine Label ), GATIFLOXACIN (Unk) (View Gatifloxacin Review and Gatifloxacin Label ).

6818556-8 | Intraocular Pressure Increased
Patient was taking Lucentis (View Usage). After Lucentis was administered, patient had the following side effects: intraocular pressure increased on Jun 29, 2010 from UNITED STATES Additional patient health information: Male patient , 66 years of age, . Lucentis dosage: . During the same period patient was treated with AVASTIN (View Avastin Review and Avastin Label ).

6818530-1 | Iridocyclitis, Ocular Hyperaemia
Adverse event was reported on Jun 21, 2010 by a Female patient taking Lucentis (View Usage) (Dosage: ) . Location: SWITZERLAND , 58 years of age, Patient experienced the following unwanted or unexpected effects: iridocyclitis, ocular hyperaemia. Patient was hospitalized.

6817793-6 | Abortion Spontaneous
on Jun 21, 2010 Female patient from SWITZERLAND , weighting 143.3 lb, was treated with Lucentis (View Usage). Patient had the following side effects: abortion spontaneous. Lucentis dosage: Unk.

6815745-3 | Detachment Of Retinal Pigment Epithelium, Endophthalmitis
on Jun 18, 2010 Male patient from SWITZERLAND , 85 years of age, was diagnosed with prophylaxis and was treated with Lucentis (View Usage). After Lucentis was administered, patient had the following side effects: detachment of retinal pigment epithelium, endophthalmitis. Lucentis dosage: 0.05 Ml, Unk. During the same period patient was treated with ANTIBIOTICS (NOT SPECIFIED) (Unk) (View Antibiotics (not Specified) Review and Antibiotics (not Specified) Label ), VISUDYNE (Unk) (View Visudyne Review and Visudyne Label ), LEVOFLOXACIN (Unk) (View Levofloxacin Review and Levofloxacin Label ), AVASTIN (Unk) (View Avastin Review and Avastin Label ). Patient was hospitalized.

6815662-9 | Abortion Spontaneous
Patient was taking Lucentis (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous on Jun 21, 2010 from SWITZERLAND Additional patient health information: Female patient , weighting 143.3 lb, . Lucentis dosage: .

6813719-X | Ischaemic Stroke
Adverse event was reported on Jun 21, 2010 by a Female patient taking Lucentis (View Usage) (Dosage: 0.5 Mg, Single) . Location: SWITZERLAND , weighting 121.3 lb, Patient had the following side effects: ischaemic stroke. Patient was hospitalized.

6809826-8 | Pulmonary Embolism
on Jun 17, 2010 Male patient from SWITZERLAND , 81 years of age, was treated with Lucentis (View Usage). After Lucentis was administered, patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). Lucentis dosage: .

6806474-0 | Aphasia, Blood Pressure Increased, Brain Oedema, Cerebral Haemorrhage, Hemianopia, Platelet Count Decreased
on Jun 16, 2010 Female patient from SWITZERLAND , 74 years of age, was treated with Lucentis (View Usage). Patient experienced the following unwanted or unexpected effects: aphasia (What is aphasia?), blood pressure increased, brain oedema, cerebral haemorrhage, hemianopia, platelet count decreased. Lucentis dosage: 0.5 Mg, 1/month. During the same period patient was treated with COSOPT (Unk) (View Cosopt Review and Cosopt Label ), LUMIGAN (Unk) (View Lumigan Review and Lumigan Label ), NEXIUM (Unk) (View Nexium Review and Nexium Label ). Patient was hospitalized and became disabled.

6806094-8 | Cerebrovascular Accident, Dizziness
Patient was taking Lucentis (View Usage). Patient had the following side effects: cerebrovascular accident, dizziness (What is dizziness?) on Jun 16, 2010 from SWITZERLAND Additional patient health information: Male patient , 75 years of age, . Lucentis dosage: 0.05 Ml, Unk. Patient was hospitalized.

6803877-5 | Ischaemic Stroke
Adverse event was reported on Jun 15, 2010 by a Female patient taking Lucentis (View Usage) (Dosage: 0.5 Mg, Single) . Location: SWITZERLAND , weighting 121.3 lb, After Lucentis was administered, patient had the following side effects: ischaemic stroke. Patient was hospitalized.

6796284-5 | Choroidal Neovascularisation, Retinal Oedema, Visual Acuity Reduced
on Mar 25, 2010 Male patient from SWITZERLAND , 51 years of age, was diagnosed with choroidal neovascularisation and was treated with Lucentis (View Usage). Patient experienced the following unwanted or unexpected effects: choroidal neovascularisation, retinal oedema, visual acuity reduced. Lucentis dosage: Unk.

6796119-0 | Cerebrovascular Accident
on Jun 14, 2010 Female patient from SWITZERLAND , 74 years of age, was treated with Lucentis (View Usage). Patient had the following side effects: cerebrovascular accident. Lucentis dosage: .

6786964-X | Detachment Of Retinal Pigment Epithelium, Retinal Pigment Epithelial Tear, Vitreous Haemorrhage
Patient was taking Lucentis (View Usage). After Lucentis was administered, patient had the following side effects: detachment of retinal pigment epithelium, retinal pigment epithelial tear, vitreous haemorrhage on Jun 09, 2010 from SWITZERLAND Additional patient health information: Female patient , 74 years of age, . Lucentis dosage: 0.05 Ml, Unk.

6786963-8 | Thrombosis, Visual Acuity Reduced
Adverse event was reported on Mar 15, 2010 by a Female patient taking Lucentis (View Usage) (Dosage: Unk) was diagnosed with choroidal neovascularisation and. Location: SWITZERLAND , 76 years of age, Patient experienced the following unwanted or unexpected effects: thrombosis, visual acuity reduced.

6785055-1 | Cerebral Infarction, Dizziness, Feeling Abnormal, Nausea, Nystagmus, Ophthalmoplegia
on Jun 10, 2010 Female patient from SWITZERLAND , 75 years of age, was treated with Lucentis (View Usage). Patient had the following side effects: cerebral infarction, dizziness (What is dizziness?), feeling abnormal, nausea (What is nausea?), nystagmus, ophthalmoplegia. Lucentis dosage: Unk Mg/ml, Unk. During the same period patient was treated with LEVOTHYROXINE SODIUM (50 A?g, Unk) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), NEXIUM (20 Mg, Unk) (View Nexium Review and Nexium Label ). Patient was hospitalized.

6785042-3 | Uveitis
on Jun 04, 2010 Female patient from SWITZERLAND , 79 years of age, was treated with Lucentis (View Usage). After Lucentis was administered, patient had the following side effects: uveitis. Lucentis dosage: 0.5 Mg, Unk.

6780382-6 | Eye Haemorrhage, Vision Blurred, Visual Impairment
Patient was taking Lucentis (View Usage). Patient experienced the following unwanted or unexpected effects: eye haemorrhage, vision blurred, visual impairment on Jun 07, 2010 from SWITZERLAND Additional patient health information: Male patient , 49 years of age, weighting 194.0 lb, was diagnosed with eye haemorrhage, diabetes mellitus and. Lucentis dosage: Unk. During the same period patient was treated with METFORMIN HCL (1 Df, Bid) (View Metformin Hcl Review and Metformin Hcl Label ), ACETYLSALICYLIC ACID (100 Mg, Unk) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), SIMVASTATIN (20 Mg, Unk) (View Simvastatin Review and Simvastatin Label ), NPH INSULIN (Unk) (View Nph Insulin Review and Nph Insulin Label ).

6770674-9 | Optic Ischaemic Neuropathy, Retinal Artery Thrombosis
Adverse event was reported on Jun 02, 2010 by a Female patient taking Lucentis (View Usage) (Dosage: 10 Mg/ml, Unk) . Location: SWITZERLAND , 71 years of age, Patient had the following side effects: optic ischaemic neuropathy, retinal artery thrombosis.

6768727-4 | Retinal Pigment Epithelial Tear
on Jun 02, 2010 Female patient from SWITZERLAND , 78 years of age, was treated with Lucentis (View Usage). After Lucentis was administered, patient had the following side effects: retinal pigment epithelial tear. Lucentis dosage: 10 Mg/ml, Unk. During the same period patient was treated with ATACAND (View Atacand Review and Atacand Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), CORDARONE (View Cordarone Review and Cordarone Label ), WARAN (View Waran Review and Waran Label ).

6766903-8 | Myocardial Infarction
on May 25, 2010 Male patient from SWITZERLAND , 91 years of age, was treated with Lucentis (View Usage). Patient experienced the following unwanted or unexpected effects: myocardial infarction. Lucentis dosage: .

6764743-7 | Prostatic Haemorrhage
Patient was taking Lucentis (View Usage). Patient had the following side effects: prostatic haemorrhage on May 28, 2010 from SWITZERLAND Additional patient health information: Male patient , 67 years of age, was diagnosed with retinal disorder (What is retinal disorder?) and. Lucentis dosage: Unk, 4/month. During the same period patient was treated with LYRICA (View Lyrica Review and Lyrica Label ).

6761363-5 |
Adverse event was reported on May 31, 2010 by a Male patient taking Lucentis (View Usage) (Dosage: 0.5 Mg, Unk) was diagnosed with diabetic retinopathy and. Location: SWITZERLAND , 63 years of age, . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ), NEBIVOLOL HCL (View Nebivolol Hcl Review and Nebivolol Hcl Label ), TORASEMIDE (View Torasemide Review and Torasemide Label ), ATACAND HCT (View Atacand Hct Review and Atacand Hct Label ).

6761334-9 | Eye Haemorrhage, Injection Site Pain
on May 20, 2010 Female patient from SWITZERLAND , 85 years of age, was treated with Lucentis (View Usage). Patient experienced the following unwanted or unexpected effects: eye haemorrhage, injection site pain. Lucentis dosage: Unk.

6760755-8 | Dizziness, Vertigo Positional
on May 27, 2010 Male patient from JAPAN , weighting 156.5 lb, was treated with Lucentis (View Usage). Patient had the following side effects: dizziness (What is dizziness?), vertigo positional. Lucentis dosage: 0.05 Ml, Unk. During the same period patient was treated with VISUDYNE (Unk) (View Visudyne Review and Visudyne Label ), GATIFLOXACIN (Unk) (View Gatifloxacin Review and Gatifloxacin Label ), ADONA (Unk) (View Adona Review and Adona Label ), KALLIDINOGENASE (Unk) (View Kallidinogenase Review and Kallidinogenase Label ).

6758797-1 | Retinal Pigmentation, Visual Acuity Reduced
Patient was taking Lucentis (View Usage). After Lucentis was administered, patient had the following side effects: retinal pigmentation, visual acuity reduced on May 25, 2010 from SWITZERLAND Additional patient health information: Female patient , 86 years of age, . Lucentis dosage: Unk.

6756964-4 | Retinal Pigment Epithelial Tear
Adverse event was reported on May 25, 2010 by a Male patient taking Lucentis (View Usage) (Dosage: 0.05 Ml, Qd) . Location: SWITZERLAND , weighting 125.7 lb, Patient experienced the following unwanted or unexpected effects: retinal pigment epithelial tear. During the same period patient was treated with VISUDYNE (Unk) (View Visudyne Review and Visudyne Label ), HARNAL (View Harnal Review and Harnal Label ).

6754877-5 | Graft Complication
on May 03, 2010 Female patient from SWITZERLAND , 33 years of age, was treated with Lucentis (View Usage). Patient had the following side effects: graft complication. Lucentis dosage: 0.05 Mg/ml, Unk.

6752144-7 | Cerebrovascular Accident
on May 18, 2010 Female patient from BELGIUM , 79 years of age, was treated with Lucentis (View Usage). After Lucentis was administered, patient had the following side effects: cerebrovascular accident. Lucentis dosage: Unk. During the same period patient was treated with TENORMIN (View Tenormin Review and Tenormin Label ), MACUGEN (Unk) (View Macugen Review and Macugen Label ). Patient was hospitalized and became disabled.

6750463-1 | Extradural Haematoma, International Normalised Ratio Increased, Spinal Cord Compression, Syncope
Patient was taking Lucentis (View Usage). Patient experienced the following unwanted or unexpected effects: extradural haematoma, international normalised ratio increased, spinal cord compression, syncope on May 19, 2010 from SWITZERLAND Additional patient health information: Female patient , weighting 119.0 lb, was diagnosed with hypertension, transient ischaemic attack and. Lucentis dosage: . During the same period patient was treated with VISUDYNE (Unk) (View Visudyne Review and Visudyne Label ), MINOCYCLINE HCL (Unk) (View Minocycline Hcl Review and Minocycline Hcl Label ), DEXAMETHASONE (Unk) (View Dexamethasone Review and Dexamethasone Label ), WARFARIN (View Warfarin Review and Warfarin Label ). Patient was hospitalized and became disabled.

6747993-5 | Ischaemic Stroke
Adverse event was reported on May 20, 2010 by a Female patient taking Lucentis (View Usage) (Dosage: Unk Unk, Unk) . Location: SWITZERLAND , 77 years of age, Patient had the following side effects: ischaemic stroke. During the same period patient was treated with ADIRO (View Adiro Review and Adiro Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), SECALIP (View Secalip Review and Secalip Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PIRACETAM (View Piracetam Review and Piracetam Label ), VINCAMINE (View Vincamine Review and Vincamine Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), ESCIN (View Escin Review and Escin Label ).

6747796-1 | Keratitis Herpetic
on May 20, 2010 Female patient from UNITED STATES , weighting 7.00 lb, was diagnosed with blood pressure (What is blood pressure?), atrial fibrillation (What is atrial fibrillation?), depression (What is depression?), cardiac disorder and was treated with Lucentis (View Usage). After Lucentis was administered, patient had the following side effects: keratitis herpetic. Lucentis dosage: 0.5 Mg, Q2m. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), LIPITOR (View Lipitor Review and Lipitor Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), TYLENOL (View Tylenol Review and Tylenol Label ), EYE VITAMINS (View Eye Vitamins Review and Eye Vitamins Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6744939-0 | Dizziness, Vertigo Positional
on May 12, 2010 Male patient from SWITZERLAND , weighting 156.5 lb, was treated with Lucentis (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), vertigo positional. Lucentis dosage: 0.05 Ml, Unk. During the same period patient was treated with VISUDYNE (Unk) (View Visudyne Review and Visudyne Label ), GATIFLOXACIN (Unk) (View Gatifloxacin Review and Gatifloxacin Label ), ADONA (Unk) (View Adona Review and Adona Label ), KALLIDINOGENASE (Unk) (View Kallidinogenase Review and Kallidinogenase Label ).

6740511-7 | Malaise
Patient was taking Lucentis (View Usage). Patient had the following side effects: malaise on May 12, 2010 from SWITZERLAND Additional patient health information: Female patient , 40 years of age, . Lucentis dosage: . Patient was hospitalized.